Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells

ConclusionsSelective B cell cytotoxicity coupled with slow repopulation kinetics results in long-term, memory B cell depletion by cladribine. These may offer a new target, possibly with potential biomarker activity, for future drug development.
Source: Journal of Neurology - Category: Neurology Source Type: research